You're signed outSign in or to get full access.
Jackson Harvey
Principal at Deerfield Management Company, L.P. (series C)
About
Jackson Harvey, Ph.D., is a Principal at Deerfield Management in New York, serving on the Therapeutics investment team. In this capacity, he drives investments in early and late-stage biopharmaceutical companies, with a particular focus on therapeutics across a range of disease areas, leveraging his scientific expertise to inform investment decisions.
Prior to his principal role, Dr. Harvey joined Deerfield as an analyst in 2021 after working as a research analyst at Stifel Financial Corp., and previously as a Biotech Equity Research Associate at both Deutsche Bank and Nomura/Instinet. This career path has provided him with deep experience analyzing public and private biotech companies, especially within the pharmaceutical and biotechnology sectors.
Dr. Harvey holds a Ph.D. in Pharmacology from the Weill Cornell Graduate School of Medical Sciences and a B.S. in Biochemistry and Philosophy from Binghamton University. He is recognized for integrating a rigorous scientific approach with financial acumen, significantly contributing to Deerfield’s leadership in healthcare and therapeutics investment.
Career History
| Organization | Role | Date Range | Details |
|---|---|---|---|
| Deerfield Management | Principal | Jan 2025 to Present | — |
| Deerfield Management | Analyst | Apr 2021 to Jan 2025 | — |
| Stifel Financial Corp. | Biotech Equity Research Associate | Aug 2020 to Apr 2021 | — |
| Deutsche Bank | Biotech Equity Research Associate | Jun 2020 to Aug 2020 | — |
| Nomura | Biotech Equity Research Associate | Oct 2017 to Jun 2020 | — |
| Weill Cornell Medicine | Graduate Student | Aug 2011 to Aug 2017 | — |
| Harvard Medical School | Research Assistant | May 2010 to May 2011 | — |
| Target | Certified Pharmacy Technician | Mar 2008 to Feb 2010 | — |
| The Research Foundation of Suny | Research Assistant | Jul 2007 to Sep 2008 | — |
Education
Joan & Sanford I. Weill Medical College of Cornell University
Philosophy, Pharmacology
2011 — 2017
Harvard Extension School
2010 — 2010
Binghamton University
Bachelor of Science, Biochemistry, Philosophy
2006 — 2009
Others at Deerfield Management Company, L.P. (series C) (35)
| Name | Role | Location |
|---|---|---|
 | Partner | New York, NY , United States |
B Brian Bizoza | Partner | New York, NY , United States |
 | Partner, Head of Private Equity Capital Markets | New York, NY , United States |
H Harshita Polishetty | Analyst | New York, NY , United States |
 | Partner | New York, NY , United States |
J Jonathan Ramos | Principal | United States |
K Ken Selle | Head Trader | Wheaton, IL , United States |
K Konstantinos Aprilakis | Partner | New York, NY , United States |
 | Associate | New York, NY , United States |
M Michael Bergen | Principal | New York, NY , United States |
Similar Fund Managers
| Name | Role | Fund | Location |
|---|---|---|---|
 | Managing Director, Head of ETF and Platform Distribution | Eagle Capital Management LLC | Philadelphia, PA , United States |
A Anne Maffei | Managing Director and Partner | Eagle Capital Management LLC | New York, NY , United States |
A Andrew Szmulewicz | Portfolio Manager - Emerging Markets | Marathon Asset Management LP | New York, NY , United States |
C Christopher Cronin | Analyst | Marathon Asset Management LP | New York, NY , United States |
